by Michel van der Burg, April 25th, 2026
In early 1999, ahead of the official launch of the clinical islet transplantation program at Leiden University Medical Center (LUMC), the author conducted a pilot study to assess whether a novel islet purification method could be applied to non-human primates.
The method combined Iodixanol (Optiprep/Visipaque) with University of Wisconsin Solution (UWS) — a preservation fluid used for donor organ storage. This Iodixanol-UWS approach had proven effective for purifying pig islets since 1996, and had been trialed on human donor islets during a 1998 visit to the Diabetes Research Institute (DRI) in Miami.
Islets were isolated from four non-human primates — one cynomolgus and three rhesus macaques — whose pancreases were procured during euthanasia of animals used in unrelated studies at the Biomedical Primate Research Centre in Holland.
Islets were purified by centrifugation in the Iodixanol-UWS gradient.
Results were excellent: an average yield of 3,697 islets / gram pancreas before purification, with 94% purity and 90% recovery after purification. Viability assessments , and a 98% culture survival confirmed high islet quality.
Colleague Krista Haanstra conducted immunogenicity analyses using a Mixed Lymphocyte Islet Culture (MLIC) assay.
Biosafety protocols for non-human primate tissue proved valuable preparation for the subsequent launch of human islet isolations at LUMC later that month.
Read the full report at michelvanderburg.com/2026/04/25/
#islets #Langerhans #isolation #purification #LUMC #Leiden #primate #macaque #optiprep #iodixanol #UWS #pancreas #transplantation #diabetes #history #research #1memo #michelvanderburg
Citation: Primate Islet Isolation and Purification in Iodixanol-UWS • @1MEMO_20260425 • Michel van der Burg • Miracles.Media • michelvanderburg.com/2026/04/25/













